SEC Form 4 · accession 0001179110-16-021417
Teladoc Health, Inc. · TDOC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jason N Gorevic
Officer — President & CEO · Director
Period of report
Mar 7, 2016
Accepted (ET)
Mar 9, 2016 · 12:21 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001477449
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $12.21 | Mar 7, 2016 | A | 400,000 | A | — | Mar 7, 2026 | Common Stock | 400,000 | 400,000 | D |
| Employee Stock Option (Right to Buy)F2 | $11.98 | Mar 8, 2016 | A | 100,000 | A | — | Mar 8, 2026 | Common Stock | 100,000 | 100,000 | D |
Explanation of responses
- F1The option will vest as to 25% of the shares on March 7, 2017. The remainder of the shares will vest in 36 equal monthly installments thereafter.
- F2The option is conditioned on the Issuer achieving certain adjusted earnings targets in respect of fiscal year 2016. Any earned amount at the measuring date will vest in 36 equal installments thereafter.